Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) EBT Margin (2024 - 2025)

Historic EBT Margin for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2025 value amounting to 49.48%.

  • Day One Biopharmaceuticals' EBT Margin fell 867700.0% to 49.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 108.66%, marking a year-over-year increase of 804300.0%. This contributed to the annual value of 150.63% for FY2024, which is N/A changed from last year.
  • Day One Biopharmaceuticals' EBT Margin amounted to 49.48% in Q3 2025, which was down 867700.0% from 89.37% recorded in Q2 2025.
  • Over the past 5 years, Day One Biopharmaceuticals' EBT Margin peaked at 37.28% during Q3 2024, and registered a low of 1353.09% during Q2 2024.